Remdesivir and COVID-19
- PMID: 33068241
- PMCID: PMC7568459
- DOI: 10.1007/s11845-020-02401-5
Remdesivir and COVID-19
Conflict of interest statement
The authors declare that they have no conflicts of interest.
References
-
- World Health Organization (WHO) https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio... (Situation Reports September 2020)
-
- Sheahan TP, Sims AC, Leist SR, Schäfer A, Won J, Brown AJ, Montgomery SA, Hogg A, Babusis D, Clarke MO, Spahn JE, Bauer L, Sellers S, Porter D, Feng JY, Cihlar T, Jordan R, Denison MR, Baric RS. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun. 2020;11:222–222. doi: 10.1038/s41467-019-13940-6. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
